DANIEL ELBOGDADI MD NPI 1528186285

NPI Details

Daniel Elbogdadi, MD is a rheumatology internal medicine in Rockville, MD with 24 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Daniel Elbogdadi, MD NPI is 1528186285. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2001

The provider's business location address is:

14995 SHADY GROVE RD
SUITE 250
ROCKVILLE, MD
ZIP 20850-726
Phone: (301) 942-7600
Fax: (301) 217-9241

The NPI 1528186285 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Vitamin d-3 level (HCPCS:82306)
• Screening test for antibody to noninfectious agent (HCPCS:86255)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• Complete ultrasound scan of joint (HCPCS:76881)
• Rheumatoid factor level (HCPCS:86431)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• X-ray of knee, 3 views (HCPCS:73562)
• Uric acid level, blood (HCPCS:84550)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Screening test for autoimmune disorder (HCPCS:86038)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• X-ray of pelvis, 1-2 views (HCPCS:72170)
• X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Screening test for pathogenic organisms (HCPCS:87081)
• Crystal identification from tissue or body fluid (HCPCS:89060)
• Body fluid cell count with cell identification (HCPCS:89051)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)

The enumeration date for this NPI number is 3/27/2007 and was last updated on 4/27/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.